Pharmacology and behavioral pharmacology of the mesocortical dopamine system.
about
Computational neuropsychiatry - schizophrenia as a cognitive brain network disorderSerotonin2C receptors in the medial prefrontal cortex facilitate cocaine-induced dopamine release in the rat nucleus accumbensAlcohol and the prefrontal cortexNeuroimaging studies of striatum in cognition part II: Parkinson's diseaseDifferential effects of dopamine-directed treatments on cognitionPharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits.Environmental enrichment alters nicotine-mediated locomotor sensitization and phosphorylation of DARPP-32 and CREB in rat prefrontal cortexForced Abstinence Model of Relapse to Study Pharmacological Treatments of Substance Use DisorderAddiction to Food and Brain Reward SystemsGenetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia.Relationship of Dopamine of the Nucleus Accumbens with Intra-infralimbic Apomorphine Microinjection.Dopaminergic modulation of auditory cortex-dependent memory consolidation through mTOR.Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective.Social behavioral changes in MPTP-treated monkey model of Parkinson's disease.The dopamine imbalance hypothesis of fatigue in multiple sclerosis and other neurological disorders.The endophenotype of impulsivity: reaching consilience through behavioral, genetic, and neuroimaging approaches.Interaction of satiety and reward response to food stimulation.The role of guanfacine as a therapeutic agent to address stress-related pathophysiology in cocaine-dependent individuals.Oxytocin reverses amphetamine-induced deficits in social bonding: evidence for an interaction with nucleus accumbens dopamineMultiphasic modulation of cholinergic interneurons by nigrostriatal afferents.Activation of D1R/PKA/mTOR signaling cascade in medial prefrontal cortex underlying the antidepressant effects of l-SPD.The interrelationship of dopamine D2-like receptor availability in striatal and extrastriatal brain regions in healthy humans: a principal component analysis of [18F]fallypride bindingCortical and basal ganglia contributions to habit learning and automaticityMechanisms underlying neuro-inflammation and neurodevelopmental toxicity in the mouse neocortex following prenatal exposure to ethanolDisruption of Akt signaling decreases dopamine sensitivity in modulation of inhibitory synaptic transmission in rat prefrontal cortex.Phasic dopamine neuron activity elicits unique mesofrontal plasticity in adolescenceSustained extracellular signal-regulated kinase 1/2 phosphorylation in neonate 6-hydroxydopamine-lesioned rats after repeated D1-dopamine receptor agonist administration: implications for NMDA receptor involvementNR4A gene expression is dynamically regulated in the ventral tegmental area dopamine neurons and is related to expression of dopamine neurotransmission genes.Mood, food, and obesity.Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia.Minocycline attenuates subjective rewarding effects of dextroamphetamine in humans.Optogenetic dissection of medial prefrontal cortex circuitryDistinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites.Antidepressant actions of histone deacetylase inhibitors.Role of the ventral tegmental area in methamphetamine extinction: AMPA receptor-mediated neuroplasticity.The Neurodynamics of Cognition: A Tutorial on Computational Cognitive NeuroscienceEffect of glycine site/NMDA receptor antagonist MRZ2/576 on the conditioned place preference and locomotor activity induced by morphine in miceLinking genes to brain, behavior and neurological diseases: what can we learn from zebrafish?Risperidone pretreatment prevents elevated locomotor activity following neonatal hippocampal lesions.Sex differences in (+)-amphetamine- and (+)-methamphetamine-induced behavioral response in male and female Sprague-Dawley rats.
P2860
Q22241226-CF4600A2-0CD7-4ADB-99E2-DB36A618440DQ24596784-8677AA53-5E28-47A7-A971-0BC8C80E2451Q24608362-C8CA36C7-F940-4419-8AF5-CF9D219B880FQ26779306-152453BD-13A2-4260-9456-DCAD5F0A0735Q26801298-8791CEC5-DE38-4AC6-8C6D-26C5641B7B3CQ27687469-E64B3581-15FD-4429-96C0-E6CA578979B0Q28577179-B085E9A3-0B7E-4D5A-B919-B355CEC26727Q28972223-FE4A675A-1E88-4540-B36F-83636166D838Q29036137-2D8E6846-9EBA-4201-9A3B-9C0C94E54497Q30375583-53D1C4CC-6D33-4752-8123-ACE4DE22B85CQ30450143-A52A9DDE-84C6-4534-8016-171AB3E69A80Q30484083-526CF4D4-489D-41F6-A872-F098143F24F9Q30492329-8BF54AB5-ECF4-461E-8ABE-15CD82F649DFQ30621723-6484D75C-0D1D-412B-9794-DA2EA5A4EC81Q30917626-F36ED35D-435C-4E1F-81DB-F840922F0C8AQ31035912-A95430A9-17D7-401D-95D7-C4F22EF6B391Q33204792-802A9E24-94E7-4BEE-A1A4-0C7565729184Q33598487-6D408496-68E8-42A3-9485-198DD0C1E2EDQ33770404-680F10A3-CC3D-4CC8-ADE1-F9EF7143E311Q33770416-DD4A3408-3186-4AC4-8AAC-7360EF119EADQ33812937-20E5C8E1-6850-4008-8AAE-3134A9056951Q33821967-48A2AD52-D271-4962-9498-D34E60A8FEA1Q33823748-BCDFB6F4-9FB9-4C75-985F-736463D17280Q33890357-F73E66BE-8270-4C56-9F79-2DA0E7BC83F7Q33893744-B7933918-C5DE-4018-944C-3B384C1B417FQ33906553-E26E4A16-B493-4BC1-894F-19BA18D6B10CQ33966465-35357DD7-36BB-4343-B41E-485653656689Q34024193-4EDD8186-E8A7-4456-AA34-0EBADF170800Q34113945-C8CB182E-C6F2-4659-AB4A-DDA652859F28Q34272454-D2007A8F-FCC6-43F9-B740-79DBE3E91F1CQ34459309-29ABC6D7-32AA-4633-B272-F0468FD27157Q34660762-8D426B9E-52F8-4435-B876-6DC969E46D86Q34923951-A41A0AA5-E71C-47F5-B1A3-F11A2539BAADQ35003394-8F79800E-B398-43F7-ABD5-7DC09306FDBDQ35120472-60DA5333-350E-4B49-BD3A-25B84FBDB666Q35155347-D9879C43-8454-4CA2-85FA-B21E44CBBE91Q35166858-0DD200B0-6A09-4D84-9AE7-0D73A60D60C4Q35684395-0EA420F5-A871-479C-A197-AF629B1F96C1Q35742020-D3731EFF-C32E-4897-8DA0-F0D417F61BABQ35854907-6CABF46D-1CBE-4AF2-90F0-F0D9AD80BD67
P2860
Pharmacology and behavioral pharmacology of the mesocortical dopamine system.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pharmacology and behavioral pharmacology of the mesocortical dopamine system.
@ast
Pharmacology and behavioral pharmacology of the mesocortical dopamine system.
@en
Pharmacology and behavioral pharmacology of the mesocortical dopamine system.
@nl
type
label
Pharmacology and behavioral pharmacology of the mesocortical dopamine system.
@ast
Pharmacology and behavioral pharmacology of the mesocortical dopamine system.
@en
Pharmacology and behavioral pharmacology of the mesocortical dopamine system.
@nl
prefLabel
Pharmacology and behavioral pharmacology of the mesocortical dopamine system.
@ast
Pharmacology and behavioral pharmacology of the mesocortical dopamine system.
@en
Pharmacology and behavioral pharmacology of the mesocortical dopamine system.
@nl
P1476
Pharmacology and behavioral pharmacology of the mesocortical dopamine system.
@en
P2093
Tzschentke TM
P304
P356
10.1016/S0301-0082(00)00033-2
P577
2001-02-01T00:00:00Z